What is Maximus Inc (MMS) Stock Return on Shareholders’ Capital?

With 1.51 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.37 million shares. During the session, the Specialty Business Services company that operates in wider Industrials sector, reached to the highest price of $88.305 whereas the lowest price it dropped to was $80.95. The 52-week range on MMS shows that it touched its highest point at $93.97 and its lowest point at $76.42 during that stretch. It currently has a 1-year price target of $114.00. With its current market cap of 4.88 billion, MMS has annualized dividend of $1.20 while the current yield stands at 1.48%. Beta for the stock currently stands at 0.77.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MMS was down-trending over the past week, with a drop of -9.76%, but this was down by -10.75% over a month. Three-month performance dropped to -8.29% while six-month performance fell -6.96%. The stock gained 2.97% in the past year, while it has lost -3.33% so far this year. A look at the trailing 12-month EPS for MMS yields 4.77 with Next year EPS estimates of 5.96. For the next quarter, that number is 1.48. This implies an EPS growth rate of 60.05% for this year and -2.77% for next year. EPS is expected to grow by 12.50% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -4.69%.

Float and Shares Shorts:

At present, 61.00 million MMS shares are outstanding with a float of 59.52 million shares on hand for trading. On 2024-10-31, short shares totaled 0.77 million, which was 128.0 higher than short shares on 1727654400. In addition to Mr. Bruce L. Caswell as the firm’s President, CEO & Director, Ms. Ilene R. Baylinson serves as its General Manager of Health Services U.S.

Institutional Ownership:

Through their ownership of 0.98302 of MMS’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, MMS reported revenue of $1314929000.0 and operating income of $141739000.0. The EBITDA in the recently reported quarter was $172002000.0 and diluted EPS was $1.46.

Analysts Ratings:

In the same way, a target price assigned to a stock can also reveal much about its potential. With MMS analysts setting a high price target of 114.0 and a low target of 114.0, the average target price over the next 12 months is 114.0. Based on these targets, MMS could surge 40.62% to reach the target high and rise by 40.62% to reach the target low. Reaching the average price target will result in a growth of 40.62% from current levels.

Analysts have provided yearly estimates in a range of $6.17007 being high and $6.07992 being low. For MMS, this leads to a yearly average estimate of $6.13. The surprise factor in the prior quarter was $1.3. Based on analyst estimates, the high estimate for the next quarter is $1.45 and the low estimate is $1.41. The average estimate for the next quarter is thus $1.43.